These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1318 related items for PubMed ID: 15213206

  • 1. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
    Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH, Women's Health Initiative Memory Study.
    JAMA; 2004 Jun 23; 291(24):2947-58. PubMed ID: 15213206
    [Abstract] [Full Text] [Related]

  • 2. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study.
    Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB, Hsia J, Margolis KL, Hogan PE, Wallace R, Dailey M, Freeman R, Hays J, Women's Health Initiative Memory Study.
    JAMA; 2004 Jun 23; 291(24):2959-68. PubMed ID: 15213207
    [Abstract] [Full Text] [Related]

  • 3. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
    Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J, WHIMS Investigators.
    JAMA; 2003 May 28; 289(20):2651-62. PubMed ID: 12771112
    [Abstract] [Full Text] [Related]

  • 4. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
    Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D, WHIMS Investigators.
    JAMA; 2003 May 28; 289(20):2663-72. PubMed ID: 12771113
    [Abstract] [Full Text] [Related]

  • 5. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin.
    Heiss G, Wallace R, Anderson GL, Aragaki A, Beresford SA, Brzyski R, Chlebowski RT, Gass M, LaCroix A, Manson JE, Prentice RL, Rossouw J, Stefanick ML, WHI Investigators.
    JAMA; 2008 Mar 05; 299(9):1036-45. PubMed ID: 18319414
    [Abstract] [Full Text] [Related]

  • 6. Effects of estrogen with and without progestin on urinary incontinence.
    Hendrix SL, Cochrane BB, Nygaard IE, Handa VL, Barnabei VM, Iglesia C, Aragaki A, Naughton MJ, Wallace RB, McNeeley SG.
    JAMA; 2005 Feb 23; 293(8):935-48. PubMed ID: 15728164
    [Abstract] [Full Text] [Related]

  • 7. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.
    Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, Anderson G, Howard BV, Thomson CA, LaCroix AZ, Wactawski-Wende J, Jackson RD, Limacher M, Margolis KL, Wassertheil-Smoller S, Beresford SA, Cauley JA, Eaton CB, Gass M, Hsia J, Johnson KC, Kooperberg C, Kuller LH, Lewis CE, Liu S, Martin LW, Ockene JK, O'Sullivan MJ, Powell LH, Simon MS, Van Horn L, Vitolins MZ, Wallace RB.
    JAMA; 2013 Oct 02; 310(13):1353-68. PubMed ID: 24084921
    [Abstract] [Full Text] [Related]

  • 8. [Hormone replacement therapy and cognitive function].
    Huang CP, Hong CT, Huang IT.
    Acta Neurol Taiwan; 2006 Dec 02; 15(4):273-7. PubMed ID: 17214093
    [Abstract] [Full Text] [Related]

  • 9. Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women's Health Initiative Randomized Trial.
    Chlebowski RT, Anderson GL, Sarto GE, Haque R, Runowicz CD, Aragaki AK, Thomson CA, Howard BV, Wactawski-Wende J, Chen C, Rohan TE, Simon MS, Reed SD, Manson JE.
    J Natl Cancer Inst; 2016 Mar 02; 108(3):. PubMed ID: 26668177
    [Abstract] [Full Text] [Related]

  • 10. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.
    Chlebowski RT, Anderson GL, Aragaki AK, Manson JE, Stefanick ML, Pan K, Barrington W, Kuller LH, Simon MS, Lane D, Johnson KC, Rohan TE, Gass MLS, Cauley JA, Paskett ED, Sattari M, Prentice RL.
    JAMA; 2020 Jul 28; 324(4):369-380. PubMed ID: 32721007
    [Abstract] [Full Text] [Related]

  • 11. Effect of estrogen therapy on gallbladder disease.
    Cirillo DJ, Wallace RB, Rodabough RJ, Greenland P, LaCroix AZ, Limacher MC, Larson JC.
    JAMA; 2005 Jan 19; 293(3):330-9. PubMed ID: 15657326
    [Abstract] [Full Text] [Related]

  • 12. Estrogen plus progestin and risk of venous thrombosis.
    Cushman M, Kuller LH, Prentice R, Rodabough RJ, Psaty BM, Stafford RS, Sidney S, Rosendaal FR, Women's Health Initiative Investigators.
    JAMA; 2004 Oct 06; 292(13):1573-80. PubMed ID: 15467059
    [Abstract] [Full Text] [Related]

  • 13. Effects of combination estrogen plus progestin hormone treatment on cognition and affect.
    Resnick SM, Maki PM, Rapp SR, Espeland MA, Brunner R, Coker LH, Granek IA, Hogan P, Ockene JK, Shumaker SA, Women's Health Initiative Study of Cognitive Aging Investigators.
    J Clin Endocrinol Metab; 2006 May 06; 91(5):1802-10. PubMed ID: 16522699
    [Abstract] [Full Text] [Related]

  • 14. Effects of oral conjugated equine estrogens with or without medroxyprogesterone acetate on incident hypertension in the Women's Health Initiative hormone therapy trials.
    Swica Y, Warren MP, Manson JE, Aragaki AK, Bassuk SS, Shimbo D, Kaunitz A, Rossouw J, Stefanick ML, Womack CR.
    Menopause; 2018 Jul 06; 25(7):753-761. PubMed ID: 29381666
    [Abstract] [Full Text] [Related]

  • 15. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.
    Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J, Pettinger M, Stefanick ML, Wactawski-Wende J, Watts NB, Women's Health Initiative Investigators.
    JAMA; 2003 Oct 01; 290(13):1729-38. PubMed ID: 14519707
    [Abstract] [Full Text] [Related]

  • 16. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1995 Jan 18; 273(3):199-208. PubMed ID: 7807658
    [Abstract] [Full Text] [Related]

  • 17. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.
    Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S, Women's Health Initiative Steering Committee.
    JAMA; 2004 Apr 14; 291(14):1701-12. PubMed ID: 15082697
    [Abstract] [Full Text] [Related]

  • 18. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
    McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, Wang CY, Brunner RL, Johnson KC, Manson JE, Lewis CE, Kotchen JM, Hulka BS, Women's Health Initiative Mammogram Density Study Investigators.
    J Natl Cancer Inst; 2005 Sep 21; 97(18):1366-76. PubMed ID: 16174858
    [Abstract] [Full Text] [Related]

  • 19. Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on.
    Maki PM, Henderson VW.
    Climacteric; 2012 Jun 21; 15(3):256-62. PubMed ID: 22612612
    [Abstract] [Full Text] [Related]

  • 20. Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials.
    Manson JE, Aragaki AK, Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Chlebowski RT, Howard BV, Thomson CA, Margolis KL, Lewis CE, Stefanick ML, Jackson RD, Johnson KC, Martin LW, Shumaker SA, Espeland MA, Wactawski-Wende J, WHI Investigators.
    JAMA; 2017 Sep 12; 318(10):927-938. PubMed ID: 28898378
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 66.